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PCoronary Artery Disease
Angiographic Versus Functional Severity of
Coronary Artery Stenoses in the FAME Study
Fractional Flow Reserve Versus Angiography in Multivessel Evaluation
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Keith G. Oldroyd, MD,§ Massoud A. Leesar, MD, Peter N. Ver Lee, MD,¶
Philip A. MacCarthy, MD, PHD,# Marcel van’t Veer, MSC, PHD,* Nico H. J. Pijls, MD, PHD*
Eindhoven, the Netherlands; Stanford, California; Aalst, Belgium; Glasgow and London, United Kingdom;
Cincinnati, Ohio; and Bangor, Maine
Objectives The purpose of this study was to investigate the relationship between angiographic and functional severity of coronary
artery stenoses in the FAME (Fractional Flow Reserve Versus Angiography in Multivessel Evaluation) study.
Background It can be difficult to determine on the coronary angiogram which lesions cause ischemia. Revascularization of
coronary stenoses that induce ischemia improves a patient’s functional status and outcome. For stenoses that
do not induce ischemia, however, the benefit of revascularization is less clear.
Methods In the FAME study, routine measurement of the fractional flow reserve (FFR) was compared with angiography for
guiding percutaneous coronary intervention in patients with multivessel coronary artery disease. The use of the
FFR in addition to angiography significantly reduced the rate of all major adverse cardiac events at 1 year. Of
the 1,414 lesions (509 patients) in the FFR-guided arm of the FAME study, 1,329 were successfully assessed by
the FFR and are included in this analysis.
Results Before FFR measurement, these lesions were categorized into 50% to 70% (47% of all lesions), 71% to 90%
(39% of all lesions), and 91% to 99% (15% of all lesions) diameter stenosis by visual assessment. In the cate-
gory 50% to 70% stenosis, 35% were functionally significant (FFR 0.80) and 65% were not (FFR 0.80). In the
category 71% to 90% stenosis, 80% were functionally significant and 20% were not. In the category of subtotal
stenoses, 96% were functionally significant. Of all 509 patients with angiographically defined multivessel dis-
ease, only 235 (46%) had functional multivessel disease (2 coronary arteries with an FFR 0.80).
Conclusions Angiography is inaccurate in assessing the functional significance of a coronary stenosis when compared with
the FFR, not only in the 50% to 70% category but also in the 70% to 90% angiographic severity
category. (J Am Coll Cardiol 2010;55:2816–21) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.11.096r
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the presence of inducible ischemia related to a coronary
rtery stenosis is important in deciding whether to revascu-
arize such a stenosis. Reducing myocardial ischemia by
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009, accepted November 24, 2009.evascularization improves a patient’s functional status and
utcome, whereas revascularization of nonischemic lesions
s controversial (1–4). The recently published results of the
AME (Fractional Flow Reserve Versus Angiography in
ultivessel Evaluation) study support the evolving strategy
f revascularization of ischemic lesions and medical treat-
ent of nonischemic ones (5).
See page 2822
In patients with multivessel coronary artery disease (CAD),
t is often difficult to determine which lesions are responsible
or reversible ischemia. Noninvasive stress tests are often not
ble to accurately detect and localize ischemia (6). Therefore,
he coronary angiogram is the standard for decision making
bout revascularization in such patients. In randomized trials
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June 22, 2010:2816–21 Angiography Versus FFRvaluating coronary revascularization, as well as in daily prac-
ice in most catheterization laboratories, lesions with a diam-
ter stenosis of 50% on the angiogram are generally
onsidered for revascularization (7–9). Coronary angiography,
owever, may result in both underestimation and overestima-
ion of a lesion’s severity and is often inaccurate in predicting
hich lesions cause ischemia (10,11).
The fractional flow reserve (FFR) is an accurate and
elective index of the physiological significance of a coronary
tenosis that can be easily measured during coronary angiog-
aphy. An FFR value of 0.80 identifies ischemia-causing
oronary stenoses with an accuracy of 90% (12,13). In the
andomized FAME study, FFR-guided percutaneous cor-
nary intervention (PCI) with drug-eluting stents was
ompared with angiography-guided PCI in patients with
ultivessel CAD (5). The 1-year results of this study
howed that FFR guidance of PCI significantly decreased
he combined end point of death, myocardial infarction, and
epeat revascularization. In this current analysis, we inves-
igated the relationship between angiographic stenosis se-
erity and functional stenosis severity as measured by the
FR. We also analyzed the number of functionally signifi-
ant diseased coronary arteries (coronary arteries with an
FR 0.80) in all patients with angiographic 2- and
-vessel disease in the FFR-guided arm of the FAME
tudy.
ethods
tudy population. In this subanalysis of the FAME
tudy, the relationship between angiography and the FFR
n all patients in the FFR-guided arm (n  509) was
nalyzed. The FAME study protocol was described in
etail previously (14). In brief, 1,005 patients with multives-
el disease were randomly assigned to angiography-guided
CI (n  496) or FFR-guided PCI (n  509). Before
andomization, the operator indicated all lesions with a
iameter stenosis percentage of50% requiring stenting. In
ases of angiography-guided PCI, all indicated lesions were
tented. In cases of FFR-guided PCI, patients first had FFR
easured in each diseased coronary artery and only under-
ent stenting if the FFR was0.80. The FAME study had
iberal inclusion criteria to reflect daily practice of PCI in
atients with multivessel CAD. More than 50% of all
creened patients actually participated in the study, and the
nclusion rate per participating center was 40 patients per
ear, which is high compared with other studies in this field.
xclusion criteria for the FAME study were angiographi-
ally significant left main CAD, previous coronary artery
ypass surgery, cardiogenic shock, or extremely tortuous or
alcified coronary arteries The FAME study protocol was
pproved for all participating centers by their respective
nternal review board or ethics committee.
efinitions of angiographic multivessel CAD and functional
ultivessel disease. Angiographic multivessel CAD was de-
ned as stenoses50% in at least 2 of the 3 major epicardial toronary arteries (angiographic
- or 3-vessel disease), which the
perator deemed to require stent-
ng. Before randomization, the op-
rator categorized the lesions ac-
ording to visual angiographic
tenosis severity into 50% to 70%,
1% to 90%, and 91% to 100%
iameter stenosis. In those ran-
omized to FFR guidance, if the
FR of a particular stenosis was 0.80, this stenosis was
onsidered as functionally nonsignificant and no stent was
laced. The angiographic disease in that respective artery was
hen classified as functionally not significant. The definition of
unctional 0-, 1-, 2-, or 3-vessel disease was made on the basis
f the number of main arteries with an FFR 0.80. So, a
atient with angiographic 3-vessel disease could be classified as
aving functional 0-, 1-, 2-, or 3-vessel disease, after FFR
easurements.
FR measurements. The FFR is defined as the ratio
etween distal coronary pressure and aortic pressure, both
easured simultaneously at maximal hyperemia. Distal
oronary pressure was measured with a coronary pressure
uidewire (Certus Pressure Wire, St. Jude Medical, St.
aul, Minnesota). Maximal hyperemia was induced by
ntravenous adenosine, administered at 140 g/kg/min via a
entral vein. Hyperemic pullback recordings were per-
ormed in all diseased arteries to discriminate focal from
iffuse disease.
tatistical analysis. Categorical variables are expressed as
roportions. Continuous variables are expressed as mean
nd SD. Angiographic lesion severity per category and the
espective FFR value of each specific lesion were plotted in
box-and-whisker plot to show the degree of dispersion and
kewness in the data and to identify potential outliers. The
ox-and-whisker plot was created with GraphPad Prism
ersion 2.01 software (GraphPad Software Inc., La Jolla,
alifornia).
esults
ngiographic versus functional stenosis severity. In the
FR-guided arm of the FAME study, 509 patients with
ngiographic multivessel CAD were included. The baseline
haracteristics are listed in Table 1. In these 509 patients,
,414 lesions were indicated before randomization (2.8 
.0 lesions per patient). The FFR was measured successfully
n 1,329 (94%) of the 1,414 lesions. Of the 85 lesions for
hich the FFR was not measured, in 58, it was because they
ere chronically occluded and in 27, it was due to technical
easons. These lesions were not included in this analysis. Of
ll 1,329 analyzed lesions, 620 (47%) were categorized in the
0% to 70% category, 513 (39%) in the 71% to 90% category,
nd 196 (15%) in the 91% to 99% category (Table 2, Fig. 1).
f all 1,329 lesions, 816 (61%) were below the ischemic
Abbreviations
and Acronyms
CAD  coronary artery
disease
FFR  fractional flow
reserve
PCI  percutaneous
coronary interventionhreshold (FFR 0.80). Of the stenoses in the 50% to 70%
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Angiography Versus FFR June 22, 2010:2816–21ategory by visual assessment, in 402 (65%), the FFR was
0.80 and in 218 (35%), the FFR was 0.80. Of the
tenoses in the 71% to 90% category, in 104 (20%), the FFR
as 0.80 and in 409 (80%), the FFR was 0.80.
n the 91% to 99% category, 7 (4%) stenoses had an
FR0.80 and 189 (96%) had an FFR0.80. In Figure 2,
xamples of the discrepancy between angiographic and
unctional stenosis severity are shown.
umber of significantly diseased coronary arteries from
he angiographic and functional point of view. Of the
09 patients in the FFR-guided arm, 115 (23%) had
ngiographic 3-vessel disease, and 394 (77%) had angio-
raphic 2-vessel disease (Fig. 3). Of all 115 patients with
ngiographic 3-vessel disease, 16 (14%) had functional
-vessel disease, 49 (43%) had functional 2-vessel disease,
9 (34%) had functional single-vessel disease, and 11 (9%)
ad no functional disease at all.
aseline CharacteristicsTable 1 Baseline Characteristics
Characteristic
FFR Group
(n  509)
Demographics
Age, yrs 64.6 10.3
Male sex 384 (75)
Clinical
History
Previous myocardial infarction 187 (37)
Previous PCI 146 (29)
Diabetes 123 (24)
Unstable angina 147 (29)
Left ventricular ejection fraction, % 57 11
Angiography
Indicated lesions per patient* 2.8 1.0
Total indicated lesions 1,414
Lesions measured by FFR† 1,329
Chronic total occlusions‡ 58
alues are mean SD or n (%). *Before randomization, the investigator indicated all lesions to be
ncluded in the study and classified them according to severity, by visual assessment, based on the
ngiogram. †All lesions successfully measured by the fractional flow reserve (FFR), thus excluding
ll chronic total occlusions (n  58) and all lesions not assessed by the FFR due to technical
easons (n 27). ‡Chronic total occlusions were assigned a default FFR value of 0.50 in the FAME
tudy.
PCI  percutaneous coronary intervention.
esion Characteristics per Categoryf Angiographic Stenosis SeverityTable 2 Lesion Characteristics per Categoryof Angiographic Stenosis Severity
% Stenosis by Angiography*
50% to 70%
(n  620, 47%)
71% to 90%
(n  513, 39%)
91% to 99%
(n  96, 15%)
FFR 0.80 402 (65) 104 (20) 7 (4)
FFR 0.80 218 (35) 409 (80) 189 (96)
Mean FFR for all
lesions
0.81 0.12 0.67 0.15 0.52 0.15
Mean FFR 0.80 0.89 0.05 0.87 0.05 0.87 0.04
Mean FFR 0.80 0.68 0.10 0.62 0.13 0.51 0.13
alues are n (%) or mean SD. *Before randomization, the investigator indicated all lesions to be
ncluded in the study and classified them according to severity, by visual assessment, based on thei
ngiogram. Only lesions successfully measured by fractional flow reserve (FFR) were included in
his analysis.Of all 394 patients with angiographic 2-vessel disease,
70 (43%) had functional 2-vessel disease, 176 (45%) had
unctional single-vessel disease, and 48 (12%) had no
unctional disease at all.
iscussion
he most important finding in this study is that all
tenoses with an angiographic severity of 50% to 70%,
5% were functionally nonsignificant and 35% were
unctionally significant by the FFR. Even in more severe
tenoses between 71% and 90% angiographic stenosis
everity, 20% of all lesions did not induce reversible
yocardial ischemia as established by an FFR value above
he ischemic threshold. Therefore, in patients with mul-
ivessel CAD, whether or not taking into account clinical
ata, one cannot rely on the angiogram to identify
schemia-producing lesions when assessing stenoses be-
ween 50% and 90%. Only in the angiographic stenosis
ategory 90%, visual lesion assessment corresponds well
o a lesion’s capability of inducing myocardial ischemia
ecause 96% of such lesions are functionally significant by
he FFR. Another important finding of this study is that
ssessment by the FFR of the number of functionally
ignificant diseased coronary arteries in patients with
ngiographic multivessel disease often leads to a reduc-
ion in the number of diseased coronary arteries from a
unctional point of view. Of all patients with angio-
raphic 3-vessel disease, 86% had only 2 or even less
unctionally significant diseased coronary arteries.
Myocardial ischemia causes symptoms and affects out-
ome (1–4). Therefore, the decision to revascularize a
oronary artery stenosis should be guided by the presence of
yocardial ischemia. Noninvasive stress testing, especially
Figure 1 Angiographic Severity Versus
Functional Severity of Coronary Artery Stenoses
Box-and-whisker plot showing the fractional flow reserve (FFR) values of all
lesions in the categories of 50% to 70%, 71% to 90%, and 91% to 99% diame-
ter stenosis. The red horizontal line corresponds to the FFR cut-off value for
myocardial ischemia (FFR 0.80 corresponds with myocardial ischemia).n the setting of multivessel CAD, is often inaccurate in
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June 22, 2010:2816–21 Angiography Versus FFRelecting which of several lesions are responsible for revers-
ble myocardial ischemia (6). Furthermore, noninvasive
tress testing is performed in less than one-half of the
atients undergoing elective PCI (15). As a consequence,
election of stenoses to be stented is mostly just guided by
he standard coronary angiogram. Additional functional infor-
ation by the FFR can, however, be obtained online, is more
pecific, and has a better spatial resolution (13,16–18) From
his and other studies, it is obvious that angiographic
tenosis severity corresponds poorly with the presence of
yocardial ischemia and is inferior to FFR measurements
19 –21). This is also the most probable explanation for
he favorable results of the FAME study (5), which
howed a significant decrease of 30% to 35% for all types
f events in the FFR-guided group at 1 year after PCI
ith drug-eluting stents in multivessel disease patients.
It should be realized that in all previous randomized studies
Figure 2 2 Patients With 2 Equally Severe Stenoses by Angiog
But Completely Different Functional Importance as As
A stenosis in the left anterior descending artery (A, arrow with asterisk) and a st
FAME (Fractional Flow Reserve Versus Angiography in Multivessel Evaluation) stud
visual assessment. After randomization to the FFR-guided arm of the FAME study,
0.80 in the left anterior descending artery (0.71; functionally significant). Subsequ
col. The FFR of the right coronary artery was 0.91, indicating a functionally nonsign
study in which the operator categorized both lesions as 70% to 90%. The left ante
(FFR  0.57) and treated by stent placement. The FFR of the right coronary artery
0.80. The right coronary artery was not stented. Abbreviation as in Figure 1.hat compared the different treatment modalities of CAD (i.e., sptimal medical therapy alone, optimal medical therapy with
CI, or optimal medical therapy with coronary artery bypass
urgery), the selection of lesions to be treated by PCI with
tenting was based on angiographic assessment alone—in the
est case, combined with clinical data—without certainty that
nly those lesions responsible for inducible ischemia were
tented. In the recently published SYNTAX (Synergy Between
CI With Taxus and Cardiac Surgery) study, PCI with
rug-eluting stents was inferior to coronary artery bypass
urgery in patients with angiographic 3-vessel disease (9). In
hat study, the decision to revascularize a stenosis was based on
linical data and the coronary angiogram alone. In both arms of
he SYNTAX study, the treatment goal was complete revas-
ularization from an angiographic point of view. In contrast, in
he FFR-guided arm of the FAME study, the goal was
omplete functional revascularization, and, according to the
esults of the FAME study, such a strategy was superior to the
ed by the FFR
in the right coronary artery (B, arrow with double asterisks) of a patient in the
lesions were categorized as 50% to 70% stenosis severity by the operator by
R was measured in both arteries. The FFR was below the ischemic threshold of
the left anterior descending artery was stented according to FAME study proto-
t stenosis, and was therefore not stented. (C, D) Another patient in the FAME
scending artery stenosis (C, arrow with asterisk) was functionally significant
sis (0.84) (D, arrow with double asterisks) was above the ischemic threshold ofraphy
sess
enosis
y. Both
the FF
ently,
ifican
rior de
stenotrategy of complete anatomic revascularization.
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Angiography Versus FFR June 22, 2010:2816–21Although indirect comparison among studies should be
ade with caution, one might speculate that if the PCI
rms in the SYNTAX trial, COURAGE (Clinical Out-
omes Utilizing Revascularization and Aggressive Drug
valuation) trial (7), and BARI 2D (Bypass Angioplasty
evascularization Investigation 2 Diabetes) trial (22) had
een FFR guided, it would have improved the outcome of
CI compared with the other treatment modalities. Further
andomized studies are mandatory to prove this hypothesis.
In addition to improving prognosis, a critically important
oal of revascularization is improvement of angina. Al-
hough fewer stents were used, FFR-guided PCI in the
AME study resulted in freedom from angina after 1 year in
1% of the patients, which is high compared with other
tudies with comparable patients treated by angiographically-
uided stenting or medical therapy alone (7,9). This means
hat selective stenting based on the FFR is very effective in
Figure 3
Proportions of Functionally
Diseased Coronary Arteries in Patients
With Angiographic 3- or 2-Vessel Disease
All 509 patients had 3-vessel (A) or 2-vessel (B) disease by the angiographic
coronary artery disease definition. Angiographic coronary artery disease (CAD)
is defined as the number of major epicardial coronary arteries (left anterior
descending artery, right circumflex artery, right coronary artery) with at least 1
stenosis of 50%; the minimum is 2 and the maximum is 3. In all of these
patients, the FFR was measured in all angiographically diseased coronary arter-
ies. The respective numbers of diseased coronary arteries by the definition of
functional CAD are displayed in the respective segments. Functional CAD is
defined as the number of major epicardial coronary arteries with at least 1 steno-
sis with an FFR 0.80; the minimum is 0 and the maximum is 3. VD  vessel
disease; other abbreviation as in Figure 1.liminating angina.tudy limitations. The selection of lesions in the FAME
tudy was based on the operator’s visual interpretation of the
ngiogram together with clinical data. It is well-known that
here is a high interobserver variability in assessing anatomic
oronary stenosis severity, but we do not believe that this
nduced bias in the class of lesions in this study because the
FR was measured after the lesions had been classified. This
eflects daily practice in the catheterization laboratory.
oreover, the operator knew that there was a 50% chance
hat the patient would be randomized to angiographic
uidance alone and that stenting of all identified lesions
ould be required by the protocol. Thus, the operator was
orced to only identify those lesions that he or she truly
eemed worthy of PCI based on the angiogram and clinical
ata.
onclusions
n patients with multivessel CAD, coronary angiography is
n inappropriate tool to identify ischemia-producing steno-
es as detected by the FFR. This discrepancy between
ngiographic and functional stenosis severity is not only
resent in the 50% to 70% stenosis range but also in the 71%
o 90% stenosis range.
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